Contrasting Kenvue (NYSE:KVUE) & Synergy CHC (NASDAQ:SNYR)

Synergy CHC (NASDAQ:SNYR) and Kenvue (NYSE:KVUE) are both consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability and valuation.

Earnings and Valuation

This table compares Synergy CHC and Kenvue”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Synergy CHC	$34.83 million	0.39	$2.12 million	$0.29	4.17
Kenvue	$15.12 billion	2.22	$1.47 billion	$0.77	22.75

Kenvue has higher revenue and earnings than Synergy CHC. Synergy CHC is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Synergy CHC has a beta of 3.64, indicating that its stock price is 264% more volatile than the S&P 500. Comparatively, Kenvue has a beta of 0.51, indicating that its stock price is 49% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent ratings and price targets for Synergy CHC and Kenvue, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Synergy CHC	0	1	2	0	2.67
Kenvue	0	13	3	0	2.19

Synergy CHC currently has a consensus target price of $6.00, indicating a potential upside of 395.91%. Kenvue has a consensus target price of $19.58, indicating a potential upside of 11.81%. Given Synergy CHC’s stronger consensus rating and higher probable upside, research analysts plainly believe Synergy CHC is more favorable than Kenvue.

Profitability

This table compares Synergy CHC and Kenvue’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Synergy CHC	7.77%	-19.51%	14.25%
Kenvue	9.72%	19.72%	7.72%

Insider & Institutional Ownership

97.6% of Kenvue shares are owned by institutional investors. 56.6% of Synergy CHC shares are owned by company insiders. Comparatively, 0.2% of Kenvue shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Kenvue beats Synergy CHC on 9 of the 14 factors compared between the two stocks.

About Synergy CHC

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.

About Kenvue

Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair, sun, and other care products under the Neutrogena, Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Rogaine, and OGX brand names. The Essential Health segment offers oral and baby, women's health, wound, and other care products under the Listerine, Johnson's, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey.